---
title: "Bupropion - Nicotine Dependence"
sidebar: mydoc_sidebar
permalink: db01156-mesh-d014029-1.html
toc: false 
---


Path ID: `DB01156_MESH_D014029_1`
{% include image.html url="images/db01156-mesh-d014029-1.png" file="db01156-mesh-d014029-1.png" alt="db01156-mesh-d014029-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D016642">MESH:D016642 </a> | bupropion | Drug |
| <a href="https://identifiers.org/UniProt:Q01959">UniProt:Q01959 </a> | Sodium-dependent dopamine transporter | Protein |
| <a href="https://identifiers.org/GO:0090494">GO:0090494 </a> | dopamine uptake | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D004298">MESH:D004298 </a> | Dopamine | ChemicalSubstance |
| <a href="https://identifiers.org/UniProt:P32297">UniProt:P32297 </a> | Neuronal acetylcholine receptor subunit alpha-3 | Protein |
| <a href="https://identifiers.org/reactome:R-HSA-629587">reactome:R-HSA-629587 </a> | Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | Pathway |
| <a href="https://identifiers.org/reactome:R-HSA-629594">reactome:R-HSA-629594 </a> | Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | Pathway |
| <a href="https://identifiers.org/reactome:R-HSA-629597">reactome:R-HSA-629597 </a> | Highly calcium permeable nicotinic acetylcholine receptors | Pathway |
| <a href="https://identifiers.org/HP:0030858">HP:0030858 </a> | Addictive behavior | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D014029">MESH:D014029 </a> | Nicotine dependence | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Bupropion | DECREASES ACTIVITY OF | Sodium-Dependent Dopamine Transporter |
| Sodium-Dependent Dopamine Transporter | POSITIVELY REGULATES | Dopamine Uptake |
| Dopamine Uptake | DECREASES ABUNDANCE OF | Dopamine |
| Dopamine | NEGATIVELY CORRELATED WITH | Addictive Behavior |
| Bupropion | DECREASES ACTIVITY OF | Neuronal Acetylcholine Receptor Subunit Alpha-3 |
| Neuronal Acetylcholine Receptor Subunit Alpha-3 | PARTICIPATES IN | Highly Sodium Permeable Postsynaptic Acetylcholine Nicotinic Receptors |
| Neuronal Acetylcholine Receptor Subunit Alpha-3 | PARTICIPATES IN | Highly Calcium Permeable Postsynaptic Nicotinic Acetylcholine Receptors |
| Neuronal Acetylcholine Receptor Subunit Alpha-3 | PARTICIPATES IN | Highly Calcium Permeable Nicotinic Acetylcholine Receptors |
| Highly Sodium Permeable Postsynaptic Acetylcholine Nicotinic Receptors | POSITIVELY CORRELATED WITH | Addictive Behavior |
| Highly Calcium Permeable Postsynaptic Nicotinic Acetylcholine Receptors | POSITIVELY CORRELATED WITH | Addictive Behavior |
| Highly Calcium Permeable Nicotinic Acetylcholine Receptors | POSITIVELY CORRELATED WITH | Addictive Behavior |
| Addictive Behavior | POSITIVELY CORRELATED WITH | Nicotine Dependence |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB01156](https://go.drugbank.com/drugs/DB01156)
  - [https://en.wikipedia.org/wiki/Bupropion](https://en.wikipedia.org/wiki/Bupropion)
  - [https://pubmed.ncbi.nlm.nih.gov/10991997/](https://pubmed.ncbi.nlm.nih.gov/10991997/)
